– Week of February 23rd
(Your edge for the week ahead — built on seasonality + real market drivers)
Most retail traders look at the calendar like it’s just… a calendar.
But Wall Street doesn’t.
This is the time of year when institutions start making real portfolio decisions. Pension money rotates. Energy desks rebalance. Defensive capital repositions. And big funds quietly begin “renting” exposure to sectors that historically outperform into spring.
That’s why seasonal edges work.
Not because the market is predictable… but because human behavior is repetitive — especially when billions of dollars are forced to make the same moves every year.
So let’s get to it.
Here are this week’s Top Seasonal Stock Setups pulled directly from SuperSeasonal stats — with the “why” behind the numbers.
(And as always: for exact trade timing and management, log in to SuperSeasonals.com
Sector: Energy (Natural Gas & Oil)
Seasonal Win Rate: 83.3%
Profit Factor: 5.85
Annualized Return: 60%+
CTRA is one of those “quiet killers” in the energy space.
It doesn’t get the headlines like Exxon. It doesn’t trade like a meme stock. But seasonally? It behaves like a stock that institutions consistently accumulate heading into spring.
Why CTRA Tends to Rally This Time of Year
Late February through April is often a prime transition window for energy producers:
- Winter demand clarity is finally priced in
- Traders begin positioning for summer consumption trends
- Natural gas supply/demand expectations start shifting
- Funds rebalance commodity exposure ahead of Q2
And here’s the key retail traders miss:
Energy isn’t just about oil prices — it’s about positioning.
Big money constantly rotates in and out of the energy complex, and this is a historically reliable “rotation window.”
Intermarket Tailwind
If crude firms up, inflation expectations creep higher, or geopolitical tension flares… energy producers like CTRA tend to benefit fast.
And unlike many “story stocks,” CTRA doesn’t need hype.
It just needs money flow.
Sector: Healthcare / Pharmaceuticals
Seasonal Win Rate: 86.9%
Profit Factor: 11.06
Annualized Return: 31%+
This is one of the most interesting names on the entire list.
Because SNY isn’t just a seasonal trade…
It’s a classic example of institutional defensive rotation.
Why Sanofi Has a Seasonal Edge
Pharmaceutical giants like Sanofi often strengthen into spring because of a recurring Wall Street pattern:
- Managers “de-risk” portfolios after early-year rallies
- Capital rotates into stable cash-flow businesses
- Healthcare becomes a safety trade when uncertainty rises
And late February is often when that defensive bid begins.
Think about it:
If the market is stretched, tech is overbought, or volatility starts creeping in… fund managers don’t sell everything.
They rotate.
They park capital somewhere “safe.”
And pharma is one of the first places they go.
The Real Driver: Psychology + Risk Management
Retail traders chase momentum.
Institutions chase survivability.
Sanofi benefits from that.
And with a profit factor over 11, this setup is screaming that when this move happens… it tends to happen decisively.
(Or swap with LIN below if you prefer a non-REIT pick)
Sector: Data Center REIT
Seasonal Win Rate: 90.4%
Profit Factor: 5.85
Annualized Return: 33%+
This is one of the cleanest “spring setups” on the list.
And here’s the thing:
DLR isn’t a boring REIT anymore.
It’s a data infrastructure play.
Why DLR Has a Seasonal Tailwind
As we enter late Q1, Wall Street starts positioning for:
- AI infrastructure expansion
- cloud demand
- enterprise IT spending
- and the “digital backbone” trade
DLR often catches a bid during this window because it sits at the intersection of:
- Tech demand
- Real asset stability
- Yield sensitivity
It’s the perfect institutional compromise trade.
Not too risky. Not too defensive. Not too speculative.
Interest Rates Matter Here
DLR’s seasonal pattern tends to strengthen when bond yields stabilize or drift lower.
Because when rates stop rising, money floods back into rate-sensitive “cash-flow compounders.”
And that’s exactly what DLR is.
If DLR Doesn’t Fit the Theme… Here’s the Better Alternative:
Backup Pick: Linde (LIN)
Sector: Industrials / Specialty Chemicals
Seasonal Win Rate: 84.8%
Profit Factor: 6.31
Annualized Return: 33%+
If you’d rather avoid a REIT entirely, LIN is a beautiful substitute.
Why LIN Works Seasonally
Linde benefits from classic spring industrial strength:
- manufacturing optimism improves into Q2
- industrial demand expectations rise
- “reflation trades” quietly reappear
- and institutions buy high-quality industrial compounders
LIN is also one of those stocks that behaves like a market leader in disguise.
It’s stable. It trends. And it attracts patient money.
Which is exactly the type of money that creates repeatable seasonal patterns.
The Bigger Takeaway This Week
Here’s what stands out about this week’s best setups:
- CTRA = cyclical energy rotation
- SNY = defensive healthcare allocation
- DLR / LIN = institutional quality accumulation
That’s not random.
That’s portfolio behavior.
And this is exactly the time of year when Wall Street begins shifting from “January momentum” into “spring positioning.”
Retail traders don’t see these rotations coming.
Seasonality does.
Final Word Before Monday’s Open
If you’re a newer trader, here’s the mindset shift:
Seasonality isn’t telling you what will happen.
It’s telling you what the market is statistically biased to do — because institutions repeat the same cycles year after year.
And if you can trade with that tailwind?
You stop gambling…
…and you start stacking probabilities.
For the full trade window timing and performance breakdowns, make sure you log in to SuperSeasonals.com.
Let’s have a smart week.
Chad Shirley
Important Disclosure
This communication is for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Investing involves risk, including the possible loss of principal. Historical seasonal trends are based on past data and may not repeat in future market conditions.
Always perform your own research and consult with a qualified financial professional before making investment decisions. We may hold positions in securities mentioned at the time of publication.
